Schmeisser Hana, Hu Renqiu, Kontsek Peter, Bekisz Joseph, Zoon Kathryn
Division of Therapeutic Proteins, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD 20892, USA.
J Interferon Cytokine Res. 2002 Apr;22(4):463-72. doi: 10.1089/10799900252952253.
We compared the antigenic properties of human interferon-alpha2c (IFN-alpha2c), IFN-alpha21a, hybrids IFN-alpha21a/alpha2c, and their mutants, using a panel of 27 anti-IFN-alpha1, anti-IFN-alpha2, and anti-IFN-alpha8/1/8 monoclonal antibodies (mAb). After immunoanalysis by ELISA, we found parental IFN-alpha2c and IFN-alpha21a to be antigenically distinct. Lack of reactivity of anti-IFN-alpha1 mAb with IFN-alpha21a indicated an antigenic distinction between subtypes alpha1 and alpha21a. The antigenic properties of hybrid IFNs consisting of the N-terminal portion (1-75) of IFN-alpha21a and the C-terminal portion (76-166) of IFN-alpha2c were analyzed with mAb recognizing defined regions of IFN-alpha2c, IFN-alpha1, and IFN-alpha8/1/8. We found that extending the sequence of IFN-alpha21a up to position 95 in hybrid molecule decreased the immunoreactivity of mAb specific for the antigenic structure formed by residues --112-132-- (helix D) of IFN-alpha2c. Inserting the sequence 76-81 (loop BC) of IFN-alpha2c into the sequence of 1-95 of IFN-alpha21a restored the reactivity of anti-IFN-alpha2c mAb. Some amino acid substitutions at positions 86 and 90 (helix C) of hybrid IFN-alpha21a/alpha2c also affected the immunoreactivity of C-terminal-specific mAb, which recognize helix D, but did not influence the structure of C-terminus of IFN (aa 151-165). Changes in the structure of constructs affected not only their antiproliferative activity but also their antiviral activity on human cells.
我们使用一组27种抗α1、抗α2和抗α8/1/8干扰素单克隆抗体(mAb),比较了人α2c干扰素(IFN-α2c)、α21a干扰素、α21a/α2c杂交干扰素及其突变体的抗原特性。通过酶联免疫吸附测定(ELISA)进行免疫分析后,我们发现亲本IFN-α2c和IFN-α21a在抗原性上存在差异。抗α1干扰素mAb与IFN-α21a缺乏反应性,表明α1和α21a亚型之间存在抗原差异。用识别IFN-α2c、IFN-α1和IFN-α8/1/8特定区域的mAb分析了由IFN-α21a的N端部分(1-75)和IFN-α2c的C端部分(76-166)组成的杂交干扰素的抗原特性。我们发现,将杂交分子中IFN-α21a的序列延伸至第95位会降低对IFN-α2c中由残基-112-132-(螺旋D)形成的抗原结构具有特异性的mAb的免疫反应性。将IFN-α2c的序列76-81(环BC)插入IFN-α21a的1-95序列中,可恢复抗IFN-α2c mAb的反应性。杂交IFN-α21a/α2c在第86和90位(螺旋C)的一些氨基酸替换也影响了识别螺旋D的C端特异性mAb的免疫反应性,但不影响IFN C端(氨基酸151-165)的结构。构建体结构的变化不仅影响其抗增殖活性,还影响其对人细胞的抗病毒活性。